139 related articles for article (PubMed ID: 33215782)
1. Letter to editor "The Role of Nodal and Cripto-1 in Human Oral Squamous Cell Carcinoma".
Jain A; Ghoshal S; Pal A
Oral Dis; 2022 Jan; 28(1):245-246. PubMed ID: 33215782
[No Abstract] [Full Text] [Related]
2. The role of Nodal and Cripto-1 in human oral squamous cell carcinoma.
Daraghma H; Untiveros G; Raskind A; Iaccarino E; Sandomenico A; Ruvo M; Arnouk H; Ciancio MJ; Cuevas-Nunez M; Strizzi L
Oral Dis; 2021 Jul; 27(5):1137-1147. PubMed ID: 32916013
[TBL] [Abstract][Full Text] [Related]
3. Reply to the Letter to the Editor "'T4b' or not to 'T4b': addressing the resectability in T4b oral cavity squamous cell carcinoma".
Thavarool SB; Narendra AK
Int J Oral Maxillofac Surg; 2022 Dec; 51(12):1606. PubMed ID: 35534322
[No Abstract] [Full Text] [Related]
4. Letter regarding "Chronic mechanical irritation and oral squamous cell carcinoma: A systematic review and meta-analysis".
Xie J; Li L
Bosn J Basic Med Sci; 2021 Dec; 21(6):788. PubMed ID: 33974526
[TBL] [Abstract][Full Text] [Related]
5. Letter to the editor: is HIF-1α a viable prognostic indicator in OSCC? A critical review of a meta-analysis study.
Jayaraj R; Kumarasamy C; Madurantakam Royam M; Devi A; Baxi S
World J Surg Oncol; 2018 Jun; 16(1):111. PubMed ID: 29914529
[TBL] [Abstract][Full Text] [Related]
6. Do demographics and tumour-related factors affect nodal yield at neck dissection? A retrospective cohort study.
Lim RS; Evans L; George AP; de Alwis N; Stimpson P; Merriel S; Giddings CE; Billah B; Smith JA; Safdar A; Sigston E
J Laryngol Otol; 2017 Jan; 131(S1):S36-S40. PubMed ID: 27786150
[TBL] [Abstract][Full Text] [Related]
7. Reply: Nodal yield and topography of nodal metastases from oral cavity squamous cell carcinoma - An audit of 1004 cases undergoing primary surgical resection.
Joy A; Rao VUS
Oral Oncol; 2021 Nov; 122():105535. PubMed ID: 34662770
[No Abstract] [Full Text] [Related]
8. Reply to the letter regarding "Chronic mechanical irritation and oral squamous cell carcinoma: A systematic review and meta-analysis".
Gupta AA; Kheur S; Varadarajan S; Parveen S; Dewan H; Alhazmi YA; Raj AT; Testarelli L; Patil S
Bosn J Basic Med Sci; 2021 Dec; 21(6):787. PubMed ID: 33974525
[TBL] [Abstract][Full Text] [Related]
9. A Letter to Editor Regarding the Article "Identification of Differentially Expressed Proteins from Smokeless Tobacco Addicted Patients Suffering from Oral Squamous Cell Carcinoma".
Bareeqa SB; Ahmed SI; Samar SS; Humayun SH
Pathol Oncol Res; 2020 Oct; 26(4):2821-2822. PubMed ID: 32328975
[No Abstract] [Full Text] [Related]
10. Authors reply to the comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.
Sekar D
Oral Oncol; 2023 Feb; 137():106306. PubMed ID: 36623474
[No Abstract] [Full Text] [Related]
11. Comment on "Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma".
Singh S; Sarode G; Sengupta N; Anand R; Sarode S
J Formos Med Assoc; 2024 Mar; 123(3):415. PubMed ID: 37996324
[No Abstract] [Full Text] [Related]
12. Reply to Letter to the Editor regarding "Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma".
Arun I; Maity N; Hameed S; Jain PV; Manikantan K; Sharan R; Arun P
Head Neck; 2021 Aug; 43(8):2556. PubMed ID: 33964180
[No Abstract] [Full Text] [Related]
13. Risk Analysis in Oral Squamous Cell Carcinoma: Are We Missing Something?
Troeltzsch M; Otto S
J Oral Maxillofac Surg; 2021 Sep; 79(9):1819-1820. PubMed ID: 34153250
[No Abstract] [Full Text] [Related]
14. The effect of C-reactive protein/albumin ratio on overall survival in patients with oral squamous cell carcinoma: A meta-analysis.
Lu H; Huang MN; Li CY; Tang SJ
Asian J Surg; 2023 Apr; 46(4):1728-1730. PubMed ID: 36283873
[No Abstract] [Full Text] [Related]
15. Letter to the Editor regarding, "The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis".
Jayaraj R; Kumarasamy C; Samiappan S; Swaminathan P
Oral Oncol; 2019 Mar; 90():139-140. PubMed ID: 30579680
[No Abstract] [Full Text] [Related]
16. Outcomes for recurrent oral cavity squamous cell carcinoma: A comprehensive outlook.
Reghunadhan P; Hegde S; Thakur S; Subash A; Rao VUS
Oral Oncol; 2023 Aug; 143():106440. PubMed ID: 37290381
[No Abstract] [Full Text] [Related]
17. Chronic mechanical irritation and oral squamous cell carcinoma: A case series.
Panta P; Misra SR
Oral Oncol; 2022 Jan; 124():105669. PubMed ID: 34915257
[No Abstract] [Full Text] [Related]
18. Prognostic impact of Beta-2 Adrenergic Receptor in oral squamous cell carcinoma.
Krishna A; Singh S; Kumar V
Oral Oncol; 2022 Feb; 125():105720. PubMed ID: 35065454
[No Abstract] [Full Text] [Related]
19. The incidence and sites of distant metastases in head and neck carcinoma.
GOWEN GF; DESUTO-NAGY G
Surg Gynecol Obstet; 1963 May; 116():603-7. PubMed ID: 13949636
[No Abstract] [Full Text] [Related]
20. Re: Association between periodontal disease and oral squamous cell carcinoma: a systemic review and meta-analysis.
Sethi A; Kumar Bhagania M; Uribe Rivera A
Br J Oral Maxillofac Surg; 2023 Nov; 61(9):640. PubMed ID: 37838482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
